PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AZN vs. VONG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between AZN and VONG is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

AZN vs. VONG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AstraZeneca PLC (AZN) and Vanguard Russell 1000 Growth ETF (VONG). The values are adjusted to include any dividend payments, if applicable.

-20.00%-15.00%-10.00%-5.00%0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
-15.35%
11.08%
AZN
VONG

Key characteristics

Sharpe Ratio

AZN:

0.13

VONG:

1.98

Sortino Ratio

AZN:

0.31

VONG:

2.58

Omega Ratio

AZN:

1.04

VONG:

1.35

Calmar Ratio

AZN:

0.10

VONG:

2.65

Martin Ratio

AZN:

0.22

VONG:

10.08

Ulcer Index

AZN:

12.21%

VONG:

3.45%

Daily Std Dev

AZN:

20.59%

VONG:

17.60%

Max Drawdown

AZN:

-48.94%

VONG:

-32.72%

Current Drawdown

AZN:

-23.99%

VONG:

-2.75%

Returns By Period

In the year-to-date period, AZN achieves a 1.65% return, which is significantly higher than VONG's 1.37% return. Over the past 10 years, AZN has underperformed VONG with an annualized return of 10.01%, while VONG has yielded a comparatively higher 17.01% annualized return.


AZN

YTD

1.65%

1M

3.35%

6M

-14.87%

1Y

2.25%

5Y*

7.95%

10Y*

10.01%

VONG

YTD

1.37%

1M

1.03%

6M

12.74%

1Y

33.00%

5Y*

18.15%

10Y*

17.01%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AZN vs. VONG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AZN
The Risk-Adjusted Performance Rank of AZN is 4646
Overall Rank
The Sharpe Ratio Rank of AZN is 5151
Sharpe Ratio Rank
The Sortino Ratio Rank of AZN is 4040
Sortino Ratio Rank
The Omega Ratio Rank of AZN is 4040
Omega Ratio Rank
The Calmar Ratio Rank of AZN is 5050
Calmar Ratio Rank
The Martin Ratio Rank of AZN is 4848
Martin Ratio Rank

VONG
The Risk-Adjusted Performance Rank of VONG is 7373
Overall Rank
The Sharpe Ratio Rank of VONG is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of VONG is 7272
Sortino Ratio Rank
The Omega Ratio Rank of VONG is 7474
Omega Ratio Rank
The Calmar Ratio Rank of VONG is 7272
Calmar Ratio Rank
The Martin Ratio Rank of VONG is 7373
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AZN vs. VONG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and Vanguard Russell 1000 Growth ETF (VONG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AZN, currently valued at 0.13, compared to the broader market-2.000.002.004.000.131.98
The chart of Sortino ratio for AZN, currently valued at 0.31, compared to the broader market-4.00-2.000.002.004.000.312.58
The chart of Omega ratio for AZN, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.35
The chart of Calmar ratio for AZN, currently valued at 0.10, compared to the broader market0.002.004.006.000.102.65
The chart of Martin ratio for AZN, currently valued at 0.22, compared to the broader market-10.000.0010.0020.000.2210.08
AZN
VONG

The current AZN Sharpe Ratio is 0.13, which is lower than the VONG Sharpe Ratio of 1.98. The chart below compares the historical Sharpe Ratios of AZN and VONG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
0.13
1.98
AZN
VONG

Dividends

AZN vs. VONG - Dividend Comparison

AZN's dividend yield for the trailing twelve months is around 2.23%, more than VONG's 0.55% yield.


TTM20242023202220212020201920182017201620152014
AZN
AstraZeneca PLC
2.23%2.27%2.15%2.14%2.40%2.80%2.81%3.61%3.95%5.01%4.06%3.98%
VONG
Vanguard Russell 1000 Growth ETF
0.55%0.55%0.71%0.98%0.58%0.77%1.03%1.18%1.19%1.48%1.47%1.43%

Drawdowns

AZN vs. VONG - Drawdown Comparison

The maximum AZN drawdown since its inception was -48.94%, which is greater than VONG's maximum drawdown of -32.72%. Use the drawdown chart below to compare losses from any high point for AZN and VONG. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-23.99%
-2.75%
AZN
VONG

Volatility

AZN vs. VONG - Volatility Comparison

The current volatility for AstraZeneca PLC (AZN) is 5.99%, while Vanguard Russell 1000 Growth ETF (VONG) has a volatility of 6.31%. This indicates that AZN experiences smaller price fluctuations and is considered to be less risky than VONG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%AugustSeptemberOctoberNovemberDecember2025
5.99%
6.31%
AZN
VONG
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab